US Appeals Court Sides With AstraZeneca, Ends Pfizer Patent Challenge Over Tagrisso
AstraZeneca has secured a significant legal victory after a U.S. federal appeals court upheld a decision invalidating two patents asserted by Pfizer subsidiary Wyeth in a dispute over the blockbuster lung cancer treatment Tagrisso. The U.S. Court of Appeals for the Federal Circuit affirmed a Delaware federal court’s ruling that the patents at the center …
US Appeals Court Sides With AstraZeneca, Ends Pfizer Patent Challenge Over Tagrisso Read More »











